Nucor earnings beat by $0.08, revenue fell short of estimates
SASKATOON, Canada - Draganfly Inc. (NASDAQ:DPRO), a manufacturer in the aircraft industry, has submitted its 6-K form to the Securities and Exchange Commission (SEC) for the first quarter ending March 31, 2025. The filing, dated today, May 8, 2025, includes the company’s unaudited condensed interim consolidated financial statements and management’s discussion and analysis for the period.
In compliance with the SEC’s regulations, Draganfly’s report provides a detailed account of its financial performance for the first quarter of the fiscal year 2025. The report was signed by Paul Sun, the Chief Financial Officer of Draganfly Inc., indicating that the company has fulfilled its reporting obligations as a foreign private issuer under the rules of the Securities Exchange Act of 1934.
The SEC document includes an exhibit index with references to the financial statements and additional commentary from management. These exhibits give investors a comprehensive view of Draganfly’s financial health and operational performance during the first three months of the year.
The filing does not specify the financial results but directs to the included exhibits for detailed information. The exhibits listed in the index are as follows: Exhibit 99.1 contains the unaudited financial statements, Exhibit 99.2 includes management’s discussion and analysis, Exhibits 99.3 and 99.4 contain certifications from the CEO and CFO, respectively, and Exhibit 104 provides the interactive data file.
Draganfly Inc. has chosen to file annual reports under Form 20-F, which is indicated by a checkmark in the SEC filing. This form is used by foreign private issuers to provide a comprehensive overview of the company’s financial status and operations to the SEC and investors.
Investors and stakeholders can access the filing through the SEC’s database to review Draganfly’s performance and financial position as of March 31, 2025. The information in this article is based on the press release statement from Draganfly Inc.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.